Niacin: uses, dosing, side effects & brands

The elimination half-life of niacin is about 20 to 45 minutes — that is how long the body takes to clear half of a dose. This is the plasma elimination half-life of the parent (nicotinic acid) from the immediate-release niacin label (Niacor 500 mg tablets); the label states it "ranges from 20 to 45 minutes," reflecting rapid absorption and extensive first-pass metabolism. It is an elimination (not distribution) figure. No active metabolite outlasts the parent for the drug's lipid effect: niacin is converted to nicotinuric acid (its primary metabolite) and, via a separate pathway, to nicotinamide and downstream compounds, but the label states nicotinamide has no hypolipidemic activity and the activity of the other metabolites is unknown — so there is no longer-lived active moiety to report. Populations: the niacin labels state that NO pharmacokinetic studies were performed in older adults (>65), renal impairment, or hepatic impairment, so the label gives no half-life change for those groups (though it cautions use in renal disease and contraindicates active liver disease). Note the separate extended-release niacin products (e.g. Niaspan/niacin ER) do NOT state any numeric elimination half-life in their labels; this 20–45 minute value is from the immediate-release product. Half-life is not the same as how long a drug test can detect the drug, and it varies with age, kidney and liver function.

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run niacin against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

We track 4 niacin-containing products in the U.S.: Niaspan, Niaspan Titration Starter Pack, Niacin and Wampocap. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.

Across the brands we track, niacin is currently marketed as tablet, extended release, tablet and capsule, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Yes. Our catalog lists 1 generic niacin product alongside the brand versions. A generic has the same active ingredient and must meet the FDA's bioequivalence standard; it usually costs less. Ask your pharmacist which one your plan covers.

The FDA's Enforcement database lists at least 5 recall records whose product description mentions niacin. The most recent: Niacin Extended-release Tablets (May 27, 2026). A recall applies to specific lots, not to the drug as a whole — check the record for the affected lot numbers.